A. Cosme, M. Montes, M. Martos, I. Gil, U. Mendarte, Y. Salicio, L

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

Helicobacter pylori infection and gastric carcinoma

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Helicobacter pylori resistance to antibiotics in 2014 in France detected by phenotypic and genotypic methods A. Ducournau, L. Bénéjat, E. Sifré, E. Bessède,

Susceptibilities to clarithromycin, amoxycillin and metronidazole of Helicobacter pylori isolates from the antrum and corpus in Tokyo, Japan, 1995–2001

L. Boyanova Clinical Microbiology and Infection

Helicobacter pylori infection and gastric carcinoma

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

O.J. Dyar, G. Tebano, C. Pulcini Clinical Microbiology and Infection

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources N. Singh,

Herpes zoster in non-hospitalized children

Migrant health—a cause for concern?

The relationship between tumour necrosis factor-α gene polymorphism and susceptibility and clearance of the persistent hepatitis B virus infection in.

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

A.K. Reddy, P. Garg, I. Kaur Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Laboratory handling of Helicobacter pylori critically influences the results of in-vitro metronidazole resistance determination T.H. Henriksen, F. Lerang,

Susceptibilities to clarithromycin, amoxycillin and metronidazole of Helicobacter pylori isolates from the antrum and corpus in Tokyo, Japan, 1995–2001

R. Cantón Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Non-antibiotic strategies for sepsis

Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice? T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt

Surveillance of Legionnaires’ disease in Austria

Vector control: a cornerstone in the malaria elimination campaign

L. Gatta, C. Ricci, A. Tampieri, D. Vaira

Sofie Arens, Jan Verhaegen, Ludo Verbist

Training for the infectious diseases speciality in Norway

P. Carrillo-Santisteve, P.L. Lopalco

Laboratory diagnosis and biosafety issues of biological warfare agents

Elements of design: the knowledge on which we build

Levofloxacin in the treatment of ventilator-associated pneumonia

G. Pappas Clinical Microbiology and Infection

Metagenomics and probiotics

Effect of antioxidants on the immune response of Helicobacter pylori

Laboratory diagnosis of Clostridium difficile disease

The practice of travel medicine in Europe

Sexually acquired Zika virus: a systematic review

Systematic review of antibiotic consumption in acute care hospitals

Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union S. Bronzwaer Clinical.

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Effect of metronidazole versus standard care on length of stay of patients admitted with severe infectious mononucleosis: a randomized controlled trial

Vaccinations against respiratory tract infections at Hajj

Reducing antibiotic use in influenza: challenges and rewards

Antimicrobial drug development – the past, the present, and the future

Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,

An after-hours clinical liaison blood culture service—is it worth it?

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Clinical Microbiology and Infection

Evaluation of the performance of the Helico Blot 2

Nebulized hypertonic saline treatment in hospitalized children with moderate to severe viral bronchiolitis Z. Luo, Z. Fu, E. Liu, X. Xu, X. Fu, D. Peng,

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Survival of rhinoviruses on human fingers

The atypical pneumonias: clinical diagnosis and importance

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

B.A. Cunha Clinical Microbiology and Infection

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Usefulness of antimicrobial susceptibility in the eradication of Helicobacter pylori A. Cosme, M. Montes, M. Martos, I. Gil, U. Mendarte, Y. Salicio, L. Piñeiro, M.T. Recasens, B. Ibarra, C. Sarasqueta, L. Bujanda Clinical Microbiology and Infection Volume 19, Issue 4, Pages 379-383 (April 2013) DOI: 10.1111/j.1469-0691.2012.03844.x Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Flow diagram of subject progress through the of study phases. Clinical Microbiology and Infection 2013 19, 379-383DOI: (10.1111/j.1469-0691.2012.03844.x) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions